NewEdge Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

NewEdge Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33K	Hold	230	–	–	﹤0.01%	3822
2026 Q1	$3.19K	Hold	230	–	–	﹤0.01%	3695
2025 Q4	$3.23K	Hold	230	–	–	﹤0.01%	3783
2025 Q3	$3.22K	Hold	230	–	–	﹤0.01%	3664
2025 Q2	$3.46K	Sell	230 -5	-2%	-$71	﹤0.01%	3496
2025 Q1	$3.1K	Hold	235	–	–	﹤0.01%	3415
2024 Q4	$3.71K	Hold	235	–	–	﹤0.01%	3313
2024 Q3	$3.73K	Hold	235	–	–	﹤0.01%	3246
2024 Q2	$3.58K	Sell	235 -295	-56%	-$4.23K	﹤0.01%	3185
2024 Q1	$7.78K	Sell	530 -45	-8%	-$657	﹤0.01%	2983
2023 Q4	$8K	Buy	+575	New	+$7.69K	﹤0.01%	2950
2023 Q1	–	Sell	-22,670	Closed	-$235K	–	3987
2022 Q4	$235K	Buy	+22,670	New	+$245K	0.01%	1119

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

NewEdge Advisors's RDY Position: Q2 2026 in Review

NewEdge Advisors held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 230 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #3822.

NewEdge Advisors first reported a position in RDY in Q4 2022 and has held it in 12 quarters since. The position peaked at $235K in Q4 2022. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

NewEdge Advisors held 230 shares of Dr. Reddy's Laboratories worth $3.33K as of Q2 2026.
NewEdge Advisors left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3822 holding.
NewEdge Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 12 quarters since.
NewEdge Advisors's Dr. Reddy's Laboratories position peaked at $235K in Q4 2022.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.